Flagship explainer
What drives ADMA BIOLOGICS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $147M | FY2025 |
| |
| Income before tax | $183M | FY2025 |
|
| Operating income | $191M | FY2025 |
|
| $510M | FY2025 |
| |
| Ending assets | $624M | FY2025 |
|
| Beginning assets | $489M | FY2024 |
|
| $477M | FY2025 |
| |
| $349M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001140361-26-006815